Nexalin Technology, Inc. Payments to Acquire Short-term Investments
Nexalin Technology, Inc. (NXL) reported Payments to Acquire Short-term Investments of $5.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-08-12
- Nexalin Technology, Inc. payments to acquire short-term investments for the quarter ending 2026-06-30 was $1.00M, a 93.38% decline year-over-year.
- Nexalin Technology, Inc. payments to acquire short-term investments for the quarter ending 2026-03-31 was $4.00M, a 19.97% decline year-over-year.
- Nexalin Technology, Inc. payments to acquire short-term investments for the quarter ending 2025-12-31 was $8.76M, a 5.16% decline year-over-year.
- Nexalin Technology, Inc. payments to acquire short-term investments for the quarter ending 2025-09-30 was $11.90M, a 32.51% decline year-over-year.
- Nexalin Technology, Inc. payments to acquire short-term investments for fiscal 2025 was $40.76M, a 21.20% increase from fiscal 2024.
- Nexalin Technology, Inc. payments to acquire short-term investments for fiscal 2024 was $33.63M, a 8.16% decline from fiscal 2023.
- Nexalin Technology, Inc. payments to acquire short-term investments for fiscal 2023 was $36.62M, a 438.94% increase from fiscal 2022.
- Nexalin Technology, Inc. payments to acquire short-term investments for fiscal 2022 was $6.79M.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $5.00M 10-Q · filed 2026-08-12 | $13.76M derived: sum of 3 quarters · filed 2026-08-12 | $25.66M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $4.00M 10-Q · filed 2026-05-08 | $12.76M derived: sum of 2 quarters · filed 2026-05-08 | $24.66M derived: sum of 3 quarters · filed 2026-05-08 | $39.76M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $8.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $20.66M derived: sum of 2 quarters · filed 2026-03-25 | $35.76M derived: sum of 3 quarters · filed 2026-08-12 | $40.76M 10-K · filed 2026-03-25 |
| 2025-09-30 | $11.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $27.01M derived: sum of 2 quarters · filed 2026-08-12 | $32.00M 10-Q · filed 2025-11-14 | $41.24M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $15.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $20.10M 10-Q · filed 2026-08-12 | $29.33M derived: sum of 3 quarters · filed 2026-08-12 | $46.97M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $5.00M 10-Q · filed 2026-05-08 | $14.23M derived: sum of 2 quarters · filed 2026-05-08 | $31.87M derived: sum of 3 quarters · filed 2026-05-08 | $33.19M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $9.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $26.87M derived: sum of 2 quarters · filed 2026-03-25 | $28.19M derived: sum of 3 quarters · filed 2026-03-25 | $33.63M 10-K · filed 2026-03-25 |
| 2024-09-30 | $17.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $18.96M derived: sum of 2 quarters · filed 2025-11-14 | $24.40M 10-Q · filed 2025-11-14 | $31.75M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $6.76M 10-Q · filed 2025-08-06 | $14.11M derived: sum of 3 quarters · filed 2025-09-23 | $24.69M derived: sum of 4 quarters · filed 2025-09-23 |
| 2024-03-31 | $5.44M 10-Q · filed 2025-05-13 | $12.79M derived: sum of 2 quarters · filed 2025-09-23 | $23.37M derived: sum of 3 quarters · filed 2025-09-23 | $32.04M derived: sum of 4 quarters · filed 2025-09-23 |
| 2023-12-31 | $7.35M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-23 | $17.93M derived: sum of 2 quarters · filed 2025-09-23 | $26.60M derived: sum of 3 quarters · filed 2025-09-23 | $36.62M 10-K/A · filed 2025-09-23 |
| 2023-09-30 | $10.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $19.25M derived: sum of 2 quarters · filed 2024-11-08 | $29.27M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $8.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $18.69M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $10.02M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $6.79M 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |